EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of duration of follow‐up and lag in data collection on the performance of adaptive clinical trials

Anders Granholm iD, Theis Lange iD, Michael O Harhay iD, Aksel Karl Georg Jensen iD, Anders Perner iD, Morten Hylander Møller iD, Benjamin Skov Kaas-Hansen iD

Pharmaceutical Statistics · 2024

DOI: 10.1002/pst.2342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2024. Verfasst von Anders Granholm und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Research Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, Dagmar Marshalls Fond, Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Different combined outcome‐data lags (follow‐up durations plus data‐collection lags) may affect the performance of adaptive clinical trial designs. We assessed the influence of different outcome‐data lags (0–105 days) on the performance of various multi‐stage, adaptive trial designs (2/4 arms, with/without a common control, fixed/response‐adaptive randomisation) with undesirable binary outcomes according to different inclusion rates (3.33/6.67/10 patients/day) under scenarios with no, small, and large differences. Simulations were conducted under a Bayesian framework, with constant stopping thresholds for superiority/inferiority calibrated to keep type‐1 error rates at approximately 5%. We assessed multiple performance metrics, including mean sample sizes, event counts/probabilities, probabilities of conclusiveness, root mean squared errors (RMSEs) of the estimated effect in the selected arms, and RMSEs between the analyses at the time of stopping and the final analyses including data from all randomised patients. Performance metrics generally deteriorated when the proportions of randomised patients with available data were smaller due to longer outcome‐data lags or faster inclusion, that is, mean sample sizes, event counts/probabilities, and RMSEs were larger, while the probabilities of conclusiveness were lower. Performance metric impairments with outcome‐data lags ≤45 days were relatively smaller compared to those occurring with ≥60 days of lag. For most metrics, the effects of different outcome‐data lags and lower proportions of randomised patients with available data were larger than those of different design choices, for example, the use of fixed versus response‐adaptive randomisation. Increased outcome‐data lag substantially affected the performance of adaptive trial designs. Trialists should consider the effects of outcome‐data lags when planning adaptive trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignHumansBayes TheoremFollow-Up StudiesSample SizeData CollectionAdaptive Clinical Trials as Topic

Stichwörter der Autor:innen

adaptive trialsdata collection lagfollow-up durationssimulationtrial design

Autor:innen und Institutionen

  • Department of Intensive Care 4131, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Clinical Trials Methods and Outcomes Lab, PAIR (Palliative and Advanced Illness Research) Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Anders Granholm, Theis Lange, Michael O Harhay, Aksel Karl Georg Jensen, Anders Perner, Morten Hylander Møller, Benjamin Skov Kaas-Hansen

Förderung

  • NHLBI NIH HHS
  • Dagmar Marshalls Fond
  • Grosserer Jakob Ehrenreich og Hustru Grete Ehrenreichs Fond

Zitieren

APA

Granholm, A., Lange, T., Harhay, M. O., Jensen, A. K. G., Perner, A., Møller, M. H., & Kaas-Hansen, B. S. (2024). Effects of duration of follow‐up and lag in data collection on the performance of adaptive clinical trials. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2342

Vancouver

Granholm A, Lange T, Harhay MO, Jensen AKG, Perner A, Møller MH, et al. Effects of duration of follow‐up and lag in data collection on the performance of adaptive clinical trials. Pharmaceutical Statistics. 2024. doi:10.1002/pst.2342

BibTeX
@article{Granholm2024,
  author = {Granholm, Anders and Lange, Theis and Harhay, Michael O and Jensen, Aksel Karl Georg and Perner, Anders and Møller, Morten Hylander and Kaas-Hansen, Benjamin Skov},
  title = {Effects of duration of follow‐up and lag in data collection on the performance of adaptive clinical trials},
  journal = {Pharmaceutical Statistics},
  year = {2024},
  doi = {10.1002/pst.2342}
}
Kostenlos starten →